Stem cell therapy in stroke - PubMed (original) (raw)
Review
Stem cell therapy in stroke
F Locatelli et al. Cell Mol Life Sci. 2009 Mar.
Abstract
Recent work has focused on cell transplantation as a therapeutic option following ischemic stroke, based on animal studies showing that cells transplanted to the brain not only survive, but also lead to functional improvement. Neural degeneration after ischemia is not selective but involves different neuronal populations, as well as glial and endothelial cell types. In models of stroke, the principal mechanism by which any improvement has been observed, has been attributed to the release of trophic factors, possibly promoting endogenous repair mechanisms, reducing cell death and stimulating neurogenesis and angiogenesis. Initial human studies indicate that stem cell therapy may be technically feasible in stroke patients, however, issues still need to be addressed for use in human subjects.
Similar articles
- Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke.
Moubarik C, Guillet B, Youssef B, Codaccioni JL, Piercecchi MD, Sabatier F, Lionel P, Dou L, Foucault-Bertaud A, Velly L, Dignat-George F, Pisano P. Moubarik C, et al. Stem Cell Rev Rep. 2011 Mar;7(1):208-20. doi: 10.1007/s12015-010-9157-y. Stem Cell Rev Rep. 2011. PMID: 20526754 - Stem cell transplantation enhances endogenous brain repair after experimental stroke.
Horie N, Hiu T, Nagata I. Horie N, et al. Neurol Med Chir (Tokyo). 2015;55(2):107-12. doi: 10.2176/nmc.ra.2014-0271. Epub 2015 Jan 23. Neurol Med Chir (Tokyo). 2015. PMID: 25746304 Free PMC article. Review. - Combining Growth Factor and Stem Cell Therapy for Stroke Rehabilitation, A Review.
Asgharzade S, Talaei A, Farkhondeh T, Forouzanfar F. Asgharzade S, et al. Curr Drug Targets. 2020;21(8):781-791. doi: 10.2174/1389450121666200107100747. Curr Drug Targets. 2020. PMID: 31914912 Review. - Stem cells in stroke repair: current success and future prospects.
Gopurappilly R, Pal R, Mamidi MK, Dey S, Bhonde R, Das AK. Gopurappilly R, et al. CNS Neurol Disord Drug Targets. 2011 Sep 1;10(6):741-56. doi: 10.2174/187152711797247894. CNS Neurol Disord Drug Targets. 2011. PMID: 21838668 Review. - Growth factors, stem cells, and stroke.
Kalluri HS, Dempsey RJ. Kalluri HS, et al. Neurosurg Focus. 2008;24(3-4):E14. doi: 10.3171/FOC/2008/24/3-4/E13. Neurosurg Focus. 2008. PMID: 18341390 Review.
Cited by
- Hydrogel-Based Therapies for Ischemic and Hemorrhagic Stroke: A Comprehensive Review.
Rotaru-Zăvăleanu AD, Dinescu VC, Aldea M, Gresita A. Rotaru-Zăvăleanu AD, et al. Gels. 2024 Jul 18;10(7):476. doi: 10.3390/gels10070476. Gels. 2024. PMID: 39057499 Free PMC article. Review. - The role of mesenchymal stem cell transplantation for ischemic stroke and recent research developments.
Zhou L, Wang J, Huang J, Song X, Wu Y, Chen X, Tan Y, Yang Q. Zhou L, et al. Front Neurol. 2022 Nov 16;13:1000777. doi: 10.3389/fneur.2022.1000777. eCollection 2022. Front Neurol. 2022. PMID: 36468067 Free PMC article. Review. - Optimal therapeutic conditions for the neural stem cell-based management of ischemic stroke: a systematic review and network meta-analysis based on animal studies.
Yang Y, Hu X, Qin Q, Kong F, Peng X, Zhao J, Si J, Yang Z, Xie S. Yang Y, et al. BMC Neurol. 2022 Sep 13;22(1):345. doi: 10.1186/s12883-022-02875-z. BMC Neurol. 2022. PMID: 36096751 Free PMC article. - Endometrium Derived Stem Cells as Potential Candidates in Nervous System Repair.
Yan Y, Wang X, Zhu G. Yan Y, et al. Ann Biomed Eng. 2022 May;50(5):485-498. doi: 10.1007/s10439-022-02909-0. Epub 2022 Mar 2. Ann Biomed Eng. 2022. PMID: 35235077 Review. - Injectable biomaterial shuttles for cell therapy in stroke.
Samal J, Segura T. Samal J, et al. Brain Res Bull. 2021 Nov;176:25-42. doi: 10.1016/j.brainresbull.2021.08.002. Epub 2021 Aug 12. Brain Res Bull. 2021. PMID: 34391821 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical